CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy

por Sacchetti, Benedetto, Botticelli, Andrea, Pierelli, Luca, Nuti, Marianna, Alimandi, Maurizio
Publicado 2019

Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis

por Marchetti, Paolo, Botticelli, Andrea, Ascierto, Antonio Paolo, Curigliano, Giuseppe, Giannarelli, Diana
Publicado 2020

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

por Vici, Patrizia, Pizzuti, Laura, Krasniqi, Eriseld, Botticelli, Andrea, Ciliberto, Gennaro, Barba, Maddalena
Publicado 2020

Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score(®) Test?

por Galati, Francesca, Magri, Valentina, Moffa, Giuliana, Rizzo, Veronica, Botticelli, Andrea, Cortesi, Enrico, Pediconi, Federica
Publicado 2022

Biliary tract cancer: current challenges and future prospects

por Ghidini, Michele, Pizzo, Claudio, Botticelli, Andrea, Hahne, Jens Claus, Passalacqua, Rodolfo, Tomasello, Gianluca, Petrelli, Fausto
Publicado 2018

The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?

por Roberto, Michela, Carconi, Catia, Cerreti, Micaela, Schipilliti, Francesca Matilde, Botticelli, Andrea, Mazzuca, Federica, Marchetti, Paolo
Publicado 2021

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression

por Roberto, Michela, Falcone, Rosa, Mazzuca, Federica, Archibugi, Livia, Castaldi, Nadia, Botticelli, Andrea, Osti, Mattia Falchetto, Marchetti, Paolo
Publicado 2017

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer

por Mezi, Silvia, Botticelli, Andrea, Pomati, Giulia, Cerbelli, Bruna, Scagnoli, Simone, Amirhassankhani, Sasan, d’Amati, Giulia, Marchetti, Paolo
Publicado 2021

Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study

por Ceccarelli, Fulvia, Natalucci, Francesco, Picciariello, Licia, Olivieri, Giulio, Cirillo, Alessio, Gelibter, Alain, Picone, Vincenzo, Botticelli, Andrea, Conti, Fabrizio
Publicado 2023

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient

por Crimini, Edoardo, Roberto, Michela, Degli Effetti, Valter, Marchetti, Paolo, Botticelli, Andrea, Schipilliti, Francesca Matilde, Arrivi, Giulia, Mazzuca, Federica
Publicado 2019

Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge

por Galati, Francesca, Magri, Valentina, Arias-Cadena, Paula Andrea, Moffa, Giuliana, Rizzo, Veronica, Pasculli, Marcella, Botticelli, Andrea, Pediconi, Federica
Publicado 2023

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

por Botticelli, Andrea, Zizzari, Ilaria, Mazzuca, Federica, Ascierto, Paolo Antonio, Putignani, Lorenza, Marchetti, Luca, Napoletano, Chiara, Nuti, Marianna, Marchetti, Paolo
Publicado 2016

New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP

por Marchetti, Paolo, Antonov, Alexey, Anemona, Lucia, Vangapandou, Chaitania, Montanaro, Manuela, Botticelli, Andrea, Mauriello, Alessandro, Melino, Gerry, Catani, M. Valeria
Publicado 2021

A Regional Survey on Merkel Cell Carcinoma: A Plea for Uniform Patient Journey Modeling and Diagnostic–Therapeutic Pathway

por Roberto, Michela, Botticelli, Andrea, Caggiati, Alessio, Chiriatti, Alberto, Della Rocca, Carlo, Ferraresi, Virginia, Musicco, Felice, Pellacani, Giovanni, Marchetti, Paolo
Publicado 2022

Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in Italy

por Mazzuca, Federica, Borro, Marina, Botticelli, Andrea, Aimati, Laura, Gentile, Giovanna, Capalbo, Carlo, Maddalena, Chiara, Mazzotti, Eva, Simmaco, Maurizio, Marchetti, Paolo
Publicado 2015

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines

por Mazzuca, Federica, Onesti, Concetta Elisa, Roberto, Michela, Di Girolamo, Marco, Botticelli, Andrea, Begini, Paola, Strigari, Lidia, Marchetti, Paolo, Muscaritoli, Maurizio
Publicado 2018

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?

por Botticelli, Andrea, Cerbelli, Bruna, Lionetto, Luana, Zizzari, Ilaria, Salati, Massimiliano, Pisano, Annalinda, Federica, Mazzuca, Simmaco, Maurizio, Nuti, Marianna, Marchetti, Paolo
Publicado 2018

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options

por Grizzi, Giulia, Ghidini, Michele, Botticelli, Andrea, Tomasello, Gianluca, Ghidini, Antonio, Grossi, Francesco, Fusco, Nicola, Cabiddu, Mary, Savio, Tommaso, Petrelli, Fausto
Publicado 2020

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions

por Ralli, Massimo, Botticelli, Andrea, Visconti, Irene Claudia, Angeletti, Diletta, Fiore, Marco, Marchetti, Paolo, Lambiase, Alessandro, de Vincentiis, Marco, Greco, Antonio
Publicado 2020

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

por Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Publicado 2013